{"id":71283,"date":"2017-07-26T06:42:45","date_gmt":"2017-07-26T13:42:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2017\/07\/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart"},"modified":"2017-07-26T06:42:45","modified_gmt":"2017-07-26T13:42:45","slug":"british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2017\/07\/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart","title":{"rendered":"British billionaire Jim Mellon and high-profile partners roll the dice on an anti-aging upstart"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart.jpg\"><\/a><\/p>\n<p>When British billionaire Jim Mellon wants to map out an investment strategy, he likes to write a book first. Out of that process came his most recent <a href=\"https:\/\/www.amazon.com\/Juvenescence-Investing-longevity-Mellon-Jim\/dp\/0993047815\/?tag=lifeboatfound-20\">work<\/a> \u2014 Juvenescence: Investing in the Age of Longevity. Now he and some close associates with some of the best connections in biotech are using the book as inspiration to launch a new company \u2014 also named Juvenescence \u2014 with plans to make a big splash in anti-aging research.<\/p>\n<p><!-- Link: <a href=\"https:\/\/endpts.com\/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart\/?utm_medium=email&utm_campaign=Wednesday++July+26+2017&utm_content=Wednesday++July+26+2017+CID_8bda3a0aeb7a0ac0517ce072a4cf9dbe&utm_source=ENDPOINTS+emails&utm_term=British+billionaire+Jim+Mellon+and+high-profile+partners+roll+the+dice+on+an+anti-aging+upstart\">https:\/\/endpts.com\/british-billionaire-jim-mellon-and-high-p...ng+upstart<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>When British billionaire Jim Mellon wants to map out an investment strategy, he likes to write a book first. Out of that process came his most recent work \u2014 Juvenescence: Investing in the Age of Longevity. Now he and some close associates with some of the best connections in biotech are using the book as [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-71283","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/71283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=71283"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/71283\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=71283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=71283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=71283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}